FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and aims at eradication of Helicobacter pylori (H. pylori). Anti-Helicobacter pills represents a composition consisting of a prebiotic component in form of oligofructose and inulin, as well as a metabolic component in form of calcium lactate in the form of tablets, powder or solution. According to the disclosed method, the agent is administered orally in an effective therapeutic dose 1–3 times a day.
EFFECT: group of inventions widens the range of therapeutic agents.
14 cl, 1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ERADICATION OF HELICOBACTER PYLORI BACTERIA IN EXPERIMENTAL HELICOBACTERIOSIS IN CONVENTIONAL WHITE MICE AND A MEANS FOR ITS IMPLEMENTATION | 2020 |
|
RU2746590C1 |
HELICO-BACTERIOSIS SIMULATION METHOD | 2018 |
|
RU2690943C1 |
METHOD OF STUDY OF GASTRIC AND INTESTINAL MICROBIOTA DURING SUPPRESSION OF COLONIZATION RESISTANCE OF GASTRIC MUCOSA OF EXPERIMENTAL ANIMALS | 2019 |
|
RU2745654C1 |
ANTIBACTERIAL AGENTS AND METHOD FOR TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS, OR COLIBACILLOSIS | 2016 |
|
RU2614730C1 |
AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
MEDICINAL AGENT, PHARMACEUTICAL COMPOSITION, HELICOBACTER PYLORI GROWTH INHIBITOR AND METHOD OF ANTIHELICOBACTERY THERAPY | 2007 |
|
RU2367458C1 |
PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2501549C1 |
METHOD TO TREAT ULCEROUS DUODENAL DISEASE | 2000 |
|
RU2184558C2 |
Authors
Dates
2020-02-04—Published
2018-10-04—Filed